Recurrent prostate cancer following external beam radiotherapy: Follow-up strategies and management

This publication has 68 references indexed in Scilit:

• Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• EFFICACY OF DIGITAL RECTAL EXAMINATION AFTER RADIOTHERAPY FOR PROSTATE CANCER
  Journal of Urology, 2001
• Definitions of biochemical failure in prostate cancer following radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• The impact of irregularly rising prostate-specific antigen and “impending failure” on the apparent outcome of localized prostate cancer following radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques
  Urology, 1999
• The Correlation Between the Astro Consensus Panel Definition of Biochemical Failure and Clinical Outcome for Patients with Prostate Cancer Treated with External Beam Irradiation
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Serum Prostate-Specific Antigen Profile Following Radiotherapy for Prostate Cancer: Implications for Patterns of Failure and Definition of Cure
  Urology, 1998
• PSAdynia and other PSA-related syndromes: A new epidemic—A case history and taxonomy
  Urology, 1997